TDM-180935
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TDM-180935, covering 2025-04-24 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of TDM-180935 in Atopic Dermatitis Patients [Phase 2]